+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Neuromodulation Market by Product Type (Deep Brain Stimulation, Sacral Nerve Stimulation, Spinal Cord Stimulation), Application (Chronic Pain Management, Depression, Epilepsy), End User, Technology - Global Forecast 2025-2030- Product Image
Neuromodulation Market by Product Type (Deep Brain Stimulation, Sacral Nerve Stimulation, Spinal Cord Stimulation), Application (Chronic Pain Management, Depression, Epilepsy), End User, Technology - Global Forecast 2025-2030- Product Image
Sale

Neuromodulation Market by Product Type (Deep Brain Stimulation, Sacral Nerve Stimulation, Spinal Cord Stimulation), Application (Chronic Pain Management, Depression, Epilepsy), End User, Technology - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 185 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4968620
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Neuromodulation Market grew from USD 8.61 billion in 2024 to USD 9.66 billion in 2025. It is expected to continue growing at a CAGR of 11.61%, reaching USD 16.64 billion by 2030.

Illuminating Neuromodulation Dynamics with Focus on Emerging Therapeutic Innovations, Market Evolution Drivers, and Strategic Foundations for Industry Leaders

The field of neuromodulation has evolved into a dynamic intersection of neuroscience, engineering, and clinical practice, offering transformative pathways for treating a broad spectrum of neurological disorders. As technological innovations proliferate, stakeholders across medical, regulatory, and commercial spheres are converging to redefine therapy paradigms. This introduction establishes a contextual framework, positioning recent breakthroughs in device miniaturization, advanced electrode design, and digital health integration within the broader trajectory of market evolution.

Moreover, the convergence of artificial intelligence, real-world data analytics, and patient-centric care models is generating unprecedented research momentum. This executive summary presents an authoritative overview of these converging trends, highlighting how evolving reimbursement structures, regulatory reforms, and strategic collaborations are shaping the next frontier of therapeutic intervention. By situating emerging capabilities alongside macroeconomic drivers and stakeholder priorities, this section lays the groundwork for a nuanced exploration of market dynamics, technological inflection points, and strategic imperatives that underlie sustainable growth in this rapidly maturing arena.

Revealing Pivotal Technological Advances and Clinical Breakthroughs Redefining Neuromodulation Therapies While Catalyzing New Market Ecosystems

Neuromodulation’s landscape is being reconfigured by a series of pivotal technological breakthroughs that are propelling the field beyond traditional boundaries. Closed loop stimulation systems, which dynamically adjust therapy in real time, exemplify a major shift from fixed-pattern delivery to personalized regulation of neural circuits. Concurrently, advancements in directional electrodes are enabling greater precision in targeting specific regions of the brain or spinal cord, thereby improving efficacy while reducing adverse side effects.

Furthermore, the growing integration of noninvasive approaches-such as high-resolution transcutaneous electrical nerve stimulation and external vagus nerve devices-has expanded the therapeutic toolkit for clinicians and patients alike. Enhanced portability and ease of use are converging with remote monitoring capabilities, supporting the transition to decentralized care models. In parallel, expanding data ecosystems and machine learning algorithms are enriching clinical decision support, accelerating iterative improvements. Together, these innovations are catalyzing new clinical applications, reshaping stakeholder engagements, and opening strategic avenues for device manufacturers, healthcare providers, and research institutions.

Assessing the Multifaceted Consequences of Evolving U.S. Tariff Policies on Neuromodulation Supply Chains, Cost Structures, and Global Competitive Dynamics

The implementation of revised U.S. tariff policies has introduced multifaceted pressures across neuromodulation supply chains, influencing procurement strategies, manufacturing footprints, and cost management. Manufacturers sourcing critical components-ranging from titanium casings to specialized electronic subassemblies-are navigating a recalibrated import landscape. As duties on key inputs increase, production planners are reevaluating supplier portfolios, adopting diversified sourcing approaches, and exploring domestic manufacturing partnerships to mitigate exposure to additional levies.

In addition, regulatory compliance timelines are intersecting with tariff-driven cost escalations, compelling stakeholders to synchronize quality assurance protocols with financial forecasting. Medical device developers are increasingly factoring in cross-border logistics complexities when structuring clinical trials and scaling commercial distribution. Ultimately, these cumulative impacts are driving a strategic reassessment of regional manufacturing hubs, inventory management systems, and total landed cost models, ensuring that price pressures do not undermine patient access or slow the pace of innovation.

Unearthing Strategic Opportunities Through Detailed Product, Application, End User, and Technology Segmentation in Neuromodulation Innovations

Understanding market segmentation within neuromodulation reveals vital pathways for targeted innovation and resource allocation. Examining product type variations uncovers a spectrum that includes deep brain stimulation with both directional and ring electrode configurations, sacral nerve stimulation presented in nonrechargeable and rechargeable designs, spinal cord stimulation systems operating in closed loop and open loop modes, transcutaneous electrical nerve stimulation units offered as portable and stationary devices, and vagus nerve stimulation modalities delivered through implanted or noninvasive platforms. These distinctions underscore the importance of tailoring device form factors and delivery mechanisms to specific therapeutic contexts.

Parallel analysis by application highlights deployment in chronic pain management, depression, epilepsy, movement disorders, and urinary incontinence, each demanding bespoke stimulation parameters, clinical workflows, and patient engagement strategies. Investigating end user preferences further surfaces the distinct operational requirements of ambulatory surgical centers, home care settings, and hospital environments, which vary in terms of procedural complexity, staffing models, and reimbursement protocols. Finally, categorizing technologies into invasive and noninvasive approaches illuminates divergent development cycles, regulatory pathways, and adoption curves. Together, these segmentation lenses provide a multidimensional perspective that informs product roadmaps, clinical validation priorities, and commercial outreach initiatives.

Decoding Regional Drivers That Shape Neuromodulation Adoption, Investment Patterns, and Market Dynamics Across the Americas, EMEA, and Asia-Pacific

Regional analyses underscore the heterogeneity of neuromodulation adoption patterns and investment climates. Within the Americas, mature reimbursement frameworks and robust clinical trial infrastructures have fostered rapid uptake of advanced implantable systems, while telehealth integration is enhancing post-procedural monitoring in underserved areas. Conversely, economic pressures in certain markets have prompted device developers to introduce cost-optimized solutions and rechargeable technologies that balance performance with long-term affordability.

In Europe, Middle East & Africa, dynamic regulatory harmonization efforts, such as the European Medical Device Regulation, are guiding product launch strategies and compliance roadmaps. Partnerships between industry and regional research consortia are accelerating translational studies, particularly in refractory epilepsy and movement disorders. Meanwhile, Asia-Pacific’s expansive patient populations and rising healthcare expenditures are driving aggressive investment in domestic manufacturing capabilities and clinical infrastructure. Governments across key nations are supporting innovation through grant programs and reimbursement pilot schemes, creating fertile conditions for both local startups and global OEMs to expand their footprints.

Unveiling Competitive Strategies and Collaborative Innovations from Leading Manufacturers That Propel Neuromodulation Technology Advancements and Market Leadership

Leading industry participants are advancing neuromodulation through differentiated approaches that span strategic collaborations, portfolio diversification, and technology licensing agreements. Global medtech firms have fortified their positions by acquiring specialized startups focused on closed loop control systems, expanding their intellectual property estates, and integrating novel biomaterials into next-generation electrode designs. In parallel, joint ventures between device manufacturers and digital health companies are enabling end-to-end remote monitoring solutions that capture real-world treatment data.

Moreover, cross-sector alliances with software developers are bolstering analytics platforms for interpreting neurophysiological feedback, while partnerships with academic medical centers are streamlining clinical validation of emerging indications. Smaller innovators are leveraging agile development cycles to pilot minimally invasive stimulation techniques, securing CE marking and other regional certifications to validate efficacy. Collectively, these efforts are driving a collaborative ecosystem where shared data, co-development ventures, and licensing frameworks accelerate market entry and reinforce leadership positions.

Empowering Industry Leaders with Tactical Roadmaps to Navigate Regulatory Complexities, Accelerate Research, and Refine Neuromodulation Market Entry Strategies

To capitalize on the evolving neuromodulation landscape, industry leaders should prioritize investments in adaptive stimulation platforms that leverage closed loop feedback and machine learning analytics. Strengthening alliances with clinical investigators and academic centers will facilitate early access to emerging indications, enhancing trial design and accelerating regulatory approvals. Concurrently, diversifying supply chains through regional manufacturing collaborations can mitigate tariff risks and improve resilience against geopolitical fluctuations.

In addition, integrating digital health capabilities-such as remote patient monitoring and telemedicine interfaces-will enhance long-term adherence and expand post-operative support networks. Executives are advised to refine reimbursement strategies by engaging proactively with payers to demonstrate value through real-world evidence and pharmacoeconomic studies. Finally, fostering a culture of cross-functional innovation, where engineering, clinical, and commercial teams collaborate on iterative proof-of-concept projects, will sustain momentum and unlock new therapeutic frontiers.

Outlining Rigorous Research Methods Centered on Stakeholder Engagement, Comprehensive Data Synthesis, and Quantitative Analysis to Illuminate Neuromodulation Trends

This research employs a rigorous, mixed-method approach centered on high-impact stakeholder engagement, comprehensive literature reviews, and robust quantitative analysis. Primary research was conducted through in-depth interviews with neurosurgeons, neurologists, and procurement executives to capture firsthand perspectives on clinical efficacy, device integration challenges, and adoption drivers. Secondary data synthesis drew upon peer-reviewed journals, regulatory filings, and reputable industry publications to contextualize technological advancements and policy developments.

Quantitative methodologies included demand-side modeling of procedure volumes under varying reimbursement scenarios and sensitivity analysis of supply chain cost inputs. Qualitative frameworks, such as SWOT and PESTLE, were applied to evaluate the strategic positioning of key market players. Cross-validation of findings through expert advisory panels ensured the accuracy and relevance of conclusions, while iterative data reviews maintained alignment with emerging clinical and regulatory trends. This multifaceted methodology underpins the credibility and actionable value of the insights presented.

Consolidating Key Insights and Strategic Imperatives Highlighting the Future Trajectory of Neuromodulation Technologies, Market Pathways, and Stakeholder Priorities

This executive summary has distilled the pivotal elements shaping neuromodulation’s trajectory, from innovative device architectures and adaptive control mechanisms to the nuanced effects of tariff shifts and regional policy landscapes. By charting the interplay between product segmentation, clinical applications, end-user requirements, and technology paradigms, we have identified the critical levers that will drive future growth and patient access.

Furthermore, the analysis of competitive strategies has illuminated how strategic partnerships, licensing collaborations, and digital health integrations are accelerating time to market. Actionable recommendations have been provided to guide industry leaders in optimizing supply chain resilience, regulatory strategy, and stakeholder engagement. As neuromodulation continues to expand across new therapeutic frontiers, these insights serve as a strategic compass for navigating complexity, seizing emerging opportunities, and delivering better patient outcomes.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Deep Brain Stimulation
      • Directional
      • Ring
    • Sacral Nerve Stimulation
      • Nonrechargeable
      • Rechargeable
    • Spinal Cord Stimulation
      • Closed Loop
      • Open Loop
    • Transcutaneous Electrical Nerve Stimulation
      • Portable
      • Stationary
    • Vagus Nerve Stimulation
      • Implanted
      • Noninvasive
  • Application
    • Chronic Pain Management
    • Depression
    • Epilepsy
    • Movement Disorders
    • Urinary Incontinence
  • End User
    • Ambulatory Surgical Centers
    • Home Care
    • Hospitals
  • Technology
    • Invasive
    • Noninvasive
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Medtronic plc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Nevro Corporation
  • LivaNova PLC
  • Zynex Medical, Inc.
  • Axonics Modulation Technologies, Inc.
  • Neuronetics, Inc.
  • Nuvectra Corporation
  • ElectroCore, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing adoption of closed-loop neuromodulation systems for personalized therapy and real-time feedback
5.2. Expansion of noninvasive neuromodulation modalities like transcranial magnetic stimulation for mental health disorders
5.3. Development of next-generation implantable devices with wireless charging and remote programmability
5.4. Growing emphasis on neuromodulation solutions for chronic pain management amid opioid crisis
5.5. Integration of artificial intelligence and machine learning algorithms to optimize neuromodulation parameters
5.6. Rising investment in minimally invasive peripheral nerve stimulation for enhanced patient comfort and outcomes
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Neuromodulation Market, by Product Type
8.1. Introduction
8.2. Deep Brain Stimulation
8.2.1. Directional
8.2.2. Ring
8.3. Sacral Nerve Stimulation
8.3.1. Nonrechargeable
8.3.2. Rechargeable
8.4. Spinal Cord Stimulation
8.4.1. Closed Loop
8.4.2. Open Loop
8.5. Transcutaneous Electrical Nerve Stimulation
8.5.1. Portable
8.5.2. Stationary
8.6. Vagus Nerve Stimulation
8.6.1. Implanted
8.6.2. Noninvasive
9. Neuromodulation Market, by Application
9.1. Introduction
9.2. Chronic Pain Management
9.3. Depression
9.4. Epilepsy
9.5. Movement Disorders
9.6. Urinary Incontinence
10. Neuromodulation Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Home Care
10.4. Hospitals
11. Neuromodulation Market, by Technology
11.1. Introduction
11.2. Invasive
11.3. Noninvasive
12. Americas Neuromodulation Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Neuromodulation Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Neuromodulation Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Medtronic plc
15.3.2. Abbott Laboratories
15.3.3. Boston Scientific Corporation
15.3.4. Nevro Corporation
15.3.5. LivaNova PLC
15.3.6. Zynex Medical, Inc.
15.3.7. Axonics Modulation Technologies, Inc.
15.3.8. Neuronetics, Inc.
15.3.9. Nuvectra Corporation
15.3.10. ElectroCore, Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. NEUROMODULATION MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL NEUROMODULATION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL NEUROMODULATION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL NEUROMODULATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL NEUROMODULATION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL NEUROMODULATION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NEUROMODULATION MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NEUROMODULATION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NEUROMODULATION MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NEUROMODULATION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS NEUROMODULATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS NEUROMODULATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES NEUROMODULATION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES NEUROMODULATION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC NEUROMODULATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC NEUROMODULATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. NEUROMODULATION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. NEUROMODULATION MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. NEUROMODULATION MARKET: RESEARCHAI
FIGURE 24. NEUROMODULATION MARKET: RESEARCHSTATISTICS
FIGURE 25. NEUROMODULATION MARKET: RESEARCHCONTACTS
FIGURE 26. NEUROMODULATION MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. NEUROMODULATION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NEUROMODULATION MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL NEUROMODULATION MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL NEUROMODULATION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL NEUROMODULATION MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL NEUROMODULATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL NEUROMODULATION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL NEUROMODULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL NEUROMODULATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL NEUROMODULATION MARKET SIZE, BY DIRECTIONAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL NEUROMODULATION MARKET SIZE, BY DIRECTIONAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL NEUROMODULATION MARKET SIZE, BY RING, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL NEUROMODULATION MARKET SIZE, BY RING, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL NEUROMODULATION MARKET SIZE, BY NONRECHARGEABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL NEUROMODULATION MARKET SIZE, BY NONRECHARGEABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL NEUROMODULATION MARKET SIZE, BY RECHARGEABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL NEUROMODULATION MARKET SIZE, BY RECHARGEABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL NEUROMODULATION MARKET SIZE, BY CLOSED LOOP, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL NEUROMODULATION MARKET SIZE, BY CLOSED LOOP, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL NEUROMODULATION MARKET SIZE, BY OPEN LOOP, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL NEUROMODULATION MARKET SIZE, BY OPEN LOOP, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL NEUROMODULATION MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL NEUROMODULATION MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL NEUROMODULATION MARKET SIZE, BY PORTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL NEUROMODULATION MARKET SIZE, BY PORTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL NEUROMODULATION MARKET SIZE, BY STATIONARY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL NEUROMODULATION MARKET SIZE, BY STATIONARY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL NEUROMODULATION MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL NEUROMODULATION MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL NEUROMODULATION MARKET SIZE, BY IMPLANTED, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL NEUROMODULATION MARKET SIZE, BY IMPLANTED, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL NEUROMODULATION MARKET SIZE, BY NONINVASIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL NEUROMODULATION MARKET SIZE, BY NONINVASIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL NEUROMODULATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL NEUROMODULATION MARKET SIZE, BY CHRONIC PAIN MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL NEUROMODULATION MARKET SIZE, BY CHRONIC PAIN MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL NEUROMODULATION MARKET SIZE, BY DEPRESSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL NEUROMODULATION MARKET SIZE, BY DEPRESSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL NEUROMODULATION MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL NEUROMODULATION MARKET SIZE, BY EPILEPSY, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL NEUROMODULATION MARKET SIZE, BY MOVEMENT DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL NEUROMODULATION MARKET SIZE, BY MOVEMENT DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL NEUROMODULATION MARKET SIZE, BY URINARY INCONTINENCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL NEUROMODULATION MARKET SIZE, BY URINARY INCONTINENCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL NEUROMODULATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL NEUROMODULATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL NEUROMODULATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL NEUROMODULATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL NEUROMODULATION MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL NEUROMODULATION MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL NEUROMODULATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL NEUROMODULATION MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL NEUROMODULATION MARKET SIZE, BY INVASIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL NEUROMODULATION MARKET SIZE, BY INVASIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL NEUROMODULATION MARKET SIZE, BY NONINVASIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL NEUROMODULATION MARKET SIZE, BY NONINVASIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS NEUROMODULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS NEUROMODULATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS NEUROMODULATION MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS NEUROMODULATION MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS NEUROMODULATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS NEUROMODULATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS NEUROMODULATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS NEUROMODULATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS NEUROMODULATION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES NEUROMODULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES NEUROMODULATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES NEUROMODULATION MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES NEUROMODULATION MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES NEUROMODULATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES NEUROMODULATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES NEUROMODULATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES NEUROMODULATION MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES NEUROMODULATION MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 117. CANADA NEUROMODULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 118. CANADA NEUROMODULATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 119. CANADA NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2024 (USD MILLION)
TABLE 120. CANADA NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, 2025-2030 (USD MILLION)
TABLE 121. CANADA NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, 2018-2024 (USD MILLION)
TABLE 122. CANADA NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, 2025-2030 (USD MILLION)
TABLE 123. CANADA NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, 2018-2024 (USD MILLION)
TABLE 124. CANADA NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, 2025-2030 (USD MILLION)
TABLE 125. CANADA NEUROMODULATION MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, 2018-2024 (USD MILLION)
TABLE 126. CANADA NEUROMODULATION MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, 2025-2030 (USD MILLION)
TABLE 127. CANADA NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, 2018-2024 (USD MILLION)
TABLE 128. CANADA NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, 2025-2030 (USD MILLION)
TABLE 129. CANADA NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 130. CANADA NEUROMODULATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 131. CANADA NEUROMODULATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. CANADA NEUROMODULATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. CANADA NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 134. CANADA NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 135. MEXICO NEUROMODULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 136. MEXICO NEUROMODULATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 137. MEXICO NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2024 (USD MILLION)
TABLE 138. MEXICO NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, 2025-2030 (USD MILLION)
TABLE 139. MEXICO NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, 2018-2024 (USD MILLION)
TABLE 140. MEXICO NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, 2025-2030 (USD MILLION)
TABLE 141. MEXICO NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, 2018-2024 (USD MILLION)
TABLE 142. MEXICO NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, 2025-2030 (USD MILLION)
TABLE 143. MEXICO NEUROMODULATION MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, 2018-2024 (USD MILLION)
TABLE 144. MEXICO NEUROMODULATION MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, 2025-2030 (USD MILLION)
TABLE 145. MEXICO NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, 2018-2024 (USD MILLION)
TABLE 146. MEXICO NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, 2025-2030 (USD MILLION)
TABLE 147. MEXICO NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 148. MEXICO NEUROMODULATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 149. MEXICO NEUROMODULATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. MEXICO NEUROMODULATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. MEXICO NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 152. MEXICO NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL NEUROMODULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL NEUROMODULATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL NEUROMODULATION MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL NEUROMODULATION MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL NEUROMODULATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL NEUROMODULATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL NEUROMODULATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA NEUROMODULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA NEUROMODULATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA NEUROMODULATION MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA NEUROMODULATION MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA NEUROMODULATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA NEUROMODULATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA NEUROMODULATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM NEUROMODULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 210. UNITED KINGDOM NEUROMODULATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2024 (USD MILLION)
TABLE 212. UNITED KINGDOM NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, 2025-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, 2018-2024 (USD MILLION)
TABLE 216. UNITED KINGDOM NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, 2025-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM NEUROMODULATION MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, 2018-2024 (USD MILLION)
TABLE 218. UNITED KINGDOM NEUROMODULATION MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, 2025-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, 2018-2024 (USD MILLION)
TABLE 220. UNITED KINGDOM NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, 2025-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 222. UNITED KINGDOM NEUROMODULATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM NEUROMODULATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. UNITED KINGDOM NEUROMODULATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 226. UNITED KINGDOM NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 227. GERMANY NEUROMODULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 228. GERMANY NEUROMODULATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 229. GERMANY NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2024 (USD MILLION)
TABLE 230. GERMANY NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, 2025-2030 (USD MILLION)
TABLE 231. GERMANY NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, 2018-2024 (USD MILLION)
TABLE 232. GERMANY NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, 2025-2030 (USD MILLION)
TABLE 233. GERMANY NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, 2018-2024 (USD MILLION)
TABLE 234. GERMANY NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, 2025-2030 (USD MILLION)
TABLE 235. GERMANY NEUROMODULATION MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, 2018-2024 (USD MILLION)
TABLE 236. GERMANY NEUROMODULATION MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, 2025-2030 (USD MILLION)
TABLE 237. GERMANY NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, 2018-2024 (USD MILLION)
TABLE 238. GERMANY NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, 2025-2030 (USD MILLION)
TABLE 239. GERMANY NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 240. GERMANY NEUROMODULATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 241. GERMANY NEUROMODULATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. GERMANY NEUROMODULATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. GERMANY NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 244. GERMANY NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 245. FRANCE NEUROMODULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 246. FRANCE NEUROMODULATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 247. FRANCE NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2024 (USD MILLION)
TABLE 248. FRANCE NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, 2025-2030 (USD MILLION)
TABLE 249. FRANCE NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, 2018-2024 (USD MILLION)
TABLE 250. FRANCE NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, 2025-2030 (USD MILLION)
TABLE 251. FRANCE NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, 2018-2024 (USD MILLION)
TABLE 252. FRANCE NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, 2025-2030 (USD MILLION)
TABLE 253. FRANCE NEUROMODULATION MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, 2018-2024 (USD MILLION)
TABLE 254. FRANCE NEUROMODULATION MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, 2025-2030 (USD MILLION)
TABLE 255. FRANCE NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, 2018-2024 (USD MILLION)
TABLE 256. FRANCE NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, 2025-2030 (USD MILLION)
TABLE 257. FRANCE NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 258. FRANCE NEUROMODULATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 259. FRANCE NEUROMODULATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. FRANCE NEUROMODULATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. FRANCE NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 262. FRANCE NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 263. RUSSIA NEUROMODULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 264. RUSSIA NEUROMODULATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 265. RUSSIA NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2024 (USD MILLION)
TABLE 266. RUSSIA NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, 2025-2030 (USD MILLION)
TABLE 267. RUSSIA NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, 2018-2024 (USD MILLION)
TABLE 268. RUSSIA NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, 2025-2030 (USD MILLION)
TABLE 269. RUSSIA NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, 2018-2024 (USD MILLION)
TABLE 270. RUSSIA NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, 2025-2030 (USD MILLION)
TABLE 271. RUSSIA NEUROMODULATION MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, 2018-2024 (USD MILLION)
TABLE 272. RUSSIA NEUROMODULATION MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, 2025-2030 (USD MILLION)
TABLE 273. RUSSIA NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, 2018-2024 (USD MILLION)
TABLE 274. RUSSIA NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, 2025-2030 (USD MILLION)
TABLE 275. RUSSIA NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 276. RUSSIA NEUROMODULATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 277. RUSSIA NEUROMODULATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. RUSSIA NEUROMODULATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. RUSSIA NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 280. RUSSIA NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 281. ITALY NEUROMODULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 282. ITALY NEUROMODULATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 283. ITALY NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2024 (USD MILLION)
TABLE 284. ITALY NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, 2025-2030 (USD MILLION)
TABLE 285. ITALY NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, 2018-2024 (USD MILLION)
TABLE 286. ITALY NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, 2025-2030 (USD MILLION)
TABLE 287. ITALY NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, 2018-2024 (USD MILLION)
TABLE 288. ITALY NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, 2025-2030 (USD MILLION)
TABLE 289. ITALY NEUROMODULATION MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, 2018-2024 (USD MILLION)
TABLE 290. ITALY NEUROMODULATION MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, 2025-2030 (USD MILLION)
TABLE 291. ITALY NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, 2018-2024 (USD MILLION)
TABLE 292. ITALY NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, 2025-2030 (USD MILLION)
TABLE 293. ITALY NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 294. ITALY NEUROMODULATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 295. ITALY NEUROMODULATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. ITALY NEUROMODULATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. ITALY NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 298. ITALY NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 299. SPAIN NEUROMODULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 300. SPAIN NEUROMODULATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 301. SPAIN NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2024 (USD MILLION)
TABLE 302. SPAIN NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, 2025-2030 (USD MILLION)
TABLE 303. SPAIN NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, 2018-2024 (USD MILLION)
TABLE 304. SPAIN NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, 2025-2030 (USD MILLION)
TABLE 305. SPAIN NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, 2018-2024 (USD MILLION)
TABLE 306. SPAIN NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, 2025-2030 (USD MILLION)
TABLE 307. SPAIN NEUROMODULATION MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, 2018-2024 (USD MILLION)
TABLE 308. SPAIN NEUROMODULATION MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, 2025-2030 (USD MILLION)
TABLE 309. SPAIN NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, 2018-2024 (USD MILLION)
TABLE 310. SPAIN NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, 2025-2030 (USD MILLION)
TABLE 311. SPAIN NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 312. SPAIN NEUROMODULATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 313. SPAIN NEUROMODULATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 314. SPAIN NEUROMODULATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 315. SPAIN NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 316. SPAIN NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 317. UNITED ARAB EMIRATES NEUROMODULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 318. UNITED ARAB EMIRATES NEUROMODULATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 319. UNITED ARAB EMIRATES NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2024 (USD MILLION)
TABLE 320. UNITED ARAB EMIRATES NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, 2025-2030 (USD MILLION)
TABLE 321. UNITED ARAB EMIRATES NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, 2018-2024 (USD MILLION)
TABLE 322. UNITED ARAB EMIRATES NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, 2025-2030 (USD MILLION)
TABLE 323. UNITED ARAB EMIRATES NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, 2018-2024 (USD MILLION)
TABLE 324. UNITED ARAB EMIRATES NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, 2025-2030 (USD MILLION)
TABLE 325. UNITED ARAB EMIRATES NEUROMODULATION MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, 2018-2024 (USD MILLION)
TABLE 326. UNITED ARAB EMIRATES NEUROMODULATION MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, 2025-2030 (USD MILLION)
TABLE 327. UNITED ARAB EMIRATES NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, 2018-2024 (USD MILLION)
TABLE 328. UNITED ARAB EMIRATES NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, 2025-2030 (USD MILLION)
TABLE 329. UNITED ARAB EMIRATES NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 330. UNITED ARAB EMIRATES NEUROMODULATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 331. UNITED ARAB EMIRATES NEUROMODULATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 332. UNITED ARAB EMIRATES NEUROMODULATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 333. UNITED ARAB EMIRATES NE

Samples

Loading
LOADING...

Companies Mentioned

  • Medtronic plc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Nevro Corporation
  • LivaNova PLC
  • Zynex Medical, Inc.
  • Axonics Modulation Technologies, Inc.
  • Neuronetics, Inc.
  • Nuvectra Corporation
  • ElectroCore, Inc.

Table Information

Report AttributeDetails
No. of Pages185
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 9.66 Billion
Forecasted Market Value ( USD ) by 2030 $ 16.64 Billion
Compound Annual Growth Rate11.6%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Neuromodulation Devices Market by Device Type (Invasive Devices, Noninvasive Devices), Control Mechanism (Closed Loop, Open Loop), Technology, Age Group, Therapeutic Area, End User, Distribution Channel - Global Forecast 2025-2030 - Product Image

Neuromodulation Devices Market by Device Type (Invasive Devices, Noninvasive Devices), Control Mechanism (Closed Loop, Open Loop), Technology, Age Group, Therapeutic Area, End User, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 193 Pages
  • Global
From
Neuromodulation - Global Strategic Business Report - Product Image

Neuromodulation - Global Strategic Business Report

  • Report
  • 298 Pages
  • Global
From
Neuromodulation Market Report by Technology, Biomaterial, Application, and Region 2025-2033 - Product Image

Neuromodulation Market Report by Technology, Biomaterial, Application, and Region 2025-2033

  • Report
  • 150 Pages
  • Global
From
Neuromodulation Devices Market Size, Share & Trends Analysis By Product (Spinal Cord Stimulators, Deep Brain Stimulators), By Application (Parkinson's Disease, Chronic Pain), By End-use, By Region, 2025 - 2030 - Product Image

Neuromodulation Devices Market Size, Share & Trends Analysis By Product (Spinal Cord Stimulators, Deep Brain Stimulators), By Application (Parkinson's Disease, Chronic Pain), By End-use, By Region, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
Neuromodulation Devices Patent Landscape Report - Product Image

Neuromodulation Devices Patent Landscape Report

  • Report
  • 200 Pages
  • Global
From

About the Neuromodulation Device Market

Neuromodulation devices are medical devices used to treat neurological disorders and chronic pain. These devices are used in a variety of surgical procedures, such as deep brain stimulation, spinal cord stimulation, and sacral nerve stimulation. Neuromodulation devices are designed to deliver electrical stimulation to the nervous system, which can help reduce pain, improve movement, and restore normal functioning. Neuromodulation devices are used in a variety of surgical procedures, including neurosurgery, orthopedic surgery, and plastic surgery. In neurosurgery, neuromodulation devices are used to treat conditions such as Parkinson's disease, epilepsy, and chronic pain. In orthopedic surgery, neuromodulation devices are used to treat conditions such as spinal cord injuries, chronic pain, and muscle spasms. In plastic surgery, neuromodulation devices are used to treat conditions such as facial paralysis and facial nerve damage. Some of the companies in the neuromodulation device market include Medtronic, Boston Scientific, St. Jude Medical, Abbott, and Cyberonics. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.